Skip to main content
Log in

Clonazepam in neonatal seizures: dose regimens and therapeutic efficacy

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The attempt has been made to define the optimal dose regimen of clonazepam in newborns suffering from neonatal convulsions.

Results obtained from 22 patients (GA 28–41 weeks; PNA 4 h to 23 days) indicated that a dose of 0.1 mg/kg every 24 h was satisfactory in the majority of the patients. It is recommended as a starting regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aicardi J (1979) Recent advances in drug therapy of some forms of childhood epilepsy. Paediatrician [Suppl 1]: 119–130

  2. Andre M, Boutroy MJ, Dubruc C, Thenot JP, Bianchetti G, Sola L, Vert P, Morselli PL (1986) Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures. Eur J Clin Pharmacol 30: 585–590

    Google Scholar 

  3. Baruzzi A, Bordo B, Bossi L, Castelli D, Gerna M, Tognoni G, Zagnoni P (1977) Plasma levels of di-n-propylacetate and clonazepam in epileptic patients. Int J Clin Pharmacol Biopharm 15: 403–408

    Google Scholar 

  4. Browne TR (1978a) Drug therapy reviews: drug therapy of status epilepticus. Am J Hosp Pharm 35: 915–922

    Google Scholar 

  5. Browne TR (1978b) Clonazepam. N Engl J Med 299: 812–816

    Google Scholar 

  6. Congdon PJ, Forsythe WI (1980) Intravenous clonazepam in the treatment of status epilepticus in children. Epilepsia 21: 97–102

    Google Scholar 

  7. De Silva JAF, Puglisi CV, Munno N (1974) Determination of clonazepam and flunitrazepam in blood and urine by electron capture CLC. J Pharm Sci 63: 520–527

    Google Scholar 

  8. Dreifuss FE, Penry JK, Rose SW, Kupferberg HJ, Dyden P, Sato S (1975) Serum clonazepam concentrations in children with absence seizures. Neurology 25: 255–258

    Google Scholar 

  9. Knop HJ, Van der Kleijn E, Edmunds LC (1974) Pharmacokinetics of clonazepam in man and laboratory animals. In: Schneider et al. (eds) Clinical Pharmacology of antiepileptic drugs. Springer, Berlin Heidelberg New York, pp 247–260

    Google Scholar 

  10. Iwakawa Y, Niwa T, Suzuki H (1986) Clonazepam-induced tonic seizure. No To Hattatsu 18: 347–353

    Google Scholar 

  11. Morselli PL (1978) Clinical significance of monitoring plasma levels of benzodiazepine tranquilizers and antiepileptic drugs. In: Deniker P, Radouco-Thomas C (eds) Neuropsychopharmacology. Villeneuve Pergamon, Oxford, pp 877–888

    Google Scholar 

  12. Pinder RM, Brodgen RN, Speight TM, Avery GS (1976) Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 12: 321–361

    Google Scholar 

  13. Sato S (1989) Clonazepam. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds) Antiepileptic drugs, sed. Raven Press, New York, pp 765–784

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andre, M., Boutroy, M.J., Bianchetti, G. et al. Clonazepam in neonatal seizures: dose regimens and therapeutic efficacy. Eur J Clin Pharmacol 40, 193–195 (1991). https://doi.org/10.1007/BF00280077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280077

Key words

Navigation